| (2,4,5-trichlorophenoxy)acetic acid | decreases expression | ISO | RGD:733628 | 6480464 | 2,4,5-Trichlorophenoxyacetic Acid results in decreased expression of FMO2 mRNA | CTD | PMID:18579281 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:733628 | 6480464 | [Tetrachlorodibenzodioxin binds to AHR protein] which results in increased expression of FMO2 mRNA | CTD | PMID:16214954 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of FMO2 mRNA | CTD | PMID:21724226 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:733628 | 6480464 | Tetrachlorodibenzodioxin affects the expression of FMO2 mRNA | CTD | PMID:21570461 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:733628 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of FMO2 mRNA | CTD | PMID:18765683 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:733628 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of FMO2 mRNA | CTD | PMID:19770486 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:733628 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of FMO2 mRNA | CTD | PMID:20036217 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:733628 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of FMO2 mRNA | CTD | PMID:20036217 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:733628 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of FMO2 mRNA | CTD | PMID:19770486 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:733628 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of FMO2 mRNA | CTD | PMID:18765683 PMID:20036217 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:733627 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of FMO2 mRNA | CTD | PMID:20106945 |
| 3-methylcholanthrene | increases expression | ISO | RGD:733628 | 6480464 | Methylcholanthrene results in increased expression of FMO2 mRNA | CTD | PMID:20570689 |
| 4-(ethoxymethylene)-2-phenyloxazol-5-one | decreases expression | EXP | | 6480464 | Oxazolone results in decreased expression of FMO2 mRNA | CTD | PMID:21893156 |
| ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of FMO2 mRNA | CTD | PMID:16483693 |
| arsenic atom | decreases expression | ISO | RGD:733628 | 6480464 | Arsenic results in decreased expression of FMO2 mRNA | CTD | PMID:19654921 |
| azathioprine | increases expression | ISO | RGD:733628 | 6480464 | Azathioprine results in increased expression of FMO2 mRNA | CTD | PMID:21621594 |
| benzo[a]pyrene | increases expression | ISO | RGD:733628 | 6480464 | Benzo(a)pyrene results in increased expression of FMO2 mRNA | CTD | PMID:19770486 |
| benzo[a]pyrene | increases expression | ISO | RGD:733628 | 6480464 | Benzo(a)pyrene results in increased expression of FMO2 mRNA | CTD | PMID:19770486 more ... |
| benzo[a]pyrene | increases expression | ISO | RGD:733628 | 6480464 | Benzo(a)pyrene results in increased expression of FMO2 mRNA | CTD | PMID:21569818 PMID:19770486 |
| benzo[a]pyrene | increases expression | ISO | RGD:733628 | 6480464 | Benzo(a)pyrene results in increased expression of FMO2 mRNA | CTD | PMID:19770486 PMID:21569818 |
| chloroprene | increases expression | ISO | RGD:733628 | 6480464 | Chloroprene results in increased expression of FMO2 mRNA | CTD | PMID:23125180 |
| chloroprene | increases expression | EXP | | 6480464 | Chloroprene results in increased expression of FMO2 mRNA | CTD | PMID:23125180 |
| choline | multiple interactions | ISO | RGD:733628 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of FMO2 mRNA | CTD | PMID:20938992 |
| ciguatoxin CTX1B | affects expression | ISO | RGD:733628 | 6480464 | Ciguatoxins affects the expression of FMO2 mRNA | CTD | PMID:18353800 |
| copper(2+) sulfate | decreases expression | ISO | RGD:733628 | 6480464 | Copper Sulfate results in decreased expression of FMO2 mRNA | CTD | PMID:18579281 |
| cyclosporin A | decreases expression | ISO | RGD:733627 | 6480464 | Cyclosporine results in decreased expression of FMO2 mRNA | CTD | PMID:20106945 |
| cyclosporin A | increases expression | ISO | RGD:733628 | 6480464 | Cyclosporine results in increased expression of FMO2 mRNA | CTD | PMID:21621594 |
| cypermethrin | increases expression | ISO | RGD:733628 | 6480464 | cypermethrin results in increased expression of FMO2 mRNA | CTD | PMID:21142847 |
| diazoxide | increases expression | ISO | RGD:733628 | 6480464 | Isoproterenol results in increased expression of FMO2 mRNA | CTD | PMID:20003209 |
| ethanol | increases expression | ISO | RGD:733628 | 6480464 | Ethanol results in increased expression of FMO2 mRNA | CTD | PMID:19167417 |
| folic acid | multiple interactions | ISO | RGD:733628 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of FMO2 mRNA | CTD | PMID:20938992 |
| isoprenaline | increases expression | ISO | RGD:733628 | 6480464 | Isoproterenol results in increased expression of FMO2 mRNA | CTD | PMID:20003209 |
| L-methionine | multiple interactions | ISO | RGD:733628 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of FMO2 mRNA | CTD | PMID:20938992 |
| methimazole | decreases oxidation | ISO | RGD:733627 | 6480464 | FMO2 gene polymorphism results in decreased oxidation of Methimazole | CTD | PMID:15864117 |
| methimazole | increases oxidation | ISO | RGD:733627 | 6480464 | FMO2 protein results in increased oxidation of Methimazole | CTD | PMID:15864117 |
| methotrexate | affects expression | ISO | RGD:733628 | 6480464 | Methotrexate affects the expression of FMO2 mRNA | CTD | PMID:18502557 |
| methotrexate | increases expression | ISO | RGD:733628 | 6480464 | Methotrexate results in increased expression of FMO2 mRNA | CTD | PMID:21621594 |
| mono(2-ethylhexyl) phthalate | increases expression | EXP | | 6480464 | mono-(2-ethylhexyl)phthalate results in increased expression of FMO2 mRNA | CTD | PMID:16809437 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of FMO2 mRNA | CTD | PMID:18164116 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of FMO2 mRNA | CTD | PMID:20360939 |
| paracetamol | affects expression | ISO | RGD:733628 | 6480464 | Acetaminophen affects the expression of FMO2 mRNA | CTD | PMID:17562736 |
| phenobarbital | multiple interactions | ISO | RGD:733628 | 6480464 | NR1I3 protein affects the reaction [Phenobarbital results in increased expression of FMO2 mRNA] | CTD | PMID:19482888 |
| phenobarbital | affects expression | ISO | RGD:733628 | 6480464 | Phenobarbital affects the expression of FMO2 mRNA | CTD | PMID:23091169 |
| phenobarbital | increases expression | ISO | RGD:733628 | 6480464 | Phenobarbital results in increased expression of FMO2 mRNA | CTD | PMID:19482888 |
| pirinixic acid | multiple interactions | ISO | RGD:733628 | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of FMO2 mRNA | CTD | PMID:19710929 |
| prednisolone | increases expression | ISO | RGD:733628 | 6480464 | Prednisolone results in increased expression of FMO2 mRNA | CTD | PMID:21621594 |
| sevoflurane | affects expression | EXP | | 6480464 | sevoflurane affects the expression of FMO2 mRNA | CTD | PMID:15967596 |
| silver atom | increases expression | ISO | RGD:733628 | 6480464 | Silver results in increased expression of FMO2 mRNA | CTD | PMID:19429238 |
| silver(0) | increases expression | ISO | RGD:733628 | 6480464 | Silver results in increased expression of FMO2 mRNA | CTD | PMID:19429238 |
| tacrolimus hydrate | increases expression | ISO | RGD:733628 | 6480464 | Tacrolimus results in increased expression of FMO2 mRNA | CTD | PMID:21621594 |
| testosterone | decreases expression | ISO | RGD:733628 | 6480464 | Testosterone results in decreased expression of FMO2 mRNA | CTD | PMID:20844152 PMID:21669218 |
| testosterone | decreases expression | ISO | RGD:733628 | 6480464 | Testosterone results in decreased expression of FMO2 mRNA | CTD | PMID:21669218 PMID:20844152 |
| testosterone enanthate | affects expression | ISO | RGD:733627 | 6480464 | testosterone enanthate affects the expression of FMO2 mRNA | CTD | PMID:17440010 |
| thiourea | increases metabolic processing | ISO | RGD:733627 | 6480464 | FMO2 protein results in increased metabolism of Thiourea | CTD | PMID:12214664 |
| trimellitic anhydride | decreases expression | ISO | RGD:733628 | 6480464 | trimellitic anhydride results in decreased expression of FMO2 mRNA | CTD | PMID:19042947 |
| trimellitic anhydride | decreases expression | EXP | | 6480464 | trimellitic anhydride results in decreased expression of FMO2 mRNA | CTD | PMID:21893156 |
| valproic acid | affects expression | ISO | RGD:733628 | 6480464 | Valproic Acid affects the expression of FMO2 mRNA | CTD | PMID:17963808 |
| vancomycin | increases expression | ISO | RGD:733628 | 6480464 | Vancomycin results in increased expression of FMO2 mRNA | CTD | PMID:18930951 |
| zinc atom | decreases expression | ISO | RGD:733628 | 6480464 | Zinc deficiency results in decreased expression of FMO2 mRNA | CTD | PMID:20857495 |
| zinc(0) | decreases expression | ISO | RGD:733628 | 6480464 | Zinc deficiency results in decreased expression of FMO2 mRNA | CTD | PMID:20857495 |